Losartan influences behavioural effects of angiotensin II(3-7) in rats

Pharmacological Research

Volumn 36, Issue 4, 1997, Pages 275-283

  Karwowska Polecka, W ^a   Kulakowska A ^a   Wisniewski K ^a   Braszko, Jan J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Angiotensin II(3 7); Conditioned behaviour; Losartan; Memory; Rat

Indexed keywords

ANGIOTENSIN; APOMORPHINE; LOSARTAN POTASSIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; RECOGNITION; STEREOTYPY;

EID: 0031259601     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0239     Document Type: Article

References (57)

1. 1. Fisher-Ferraro C, Nahmod VE, Goldstein DJ, Finkielman S. Angiotensin and renin in the rat and dog brain. J Exp Med 1971; 133: 353-61.
2. 2. Ganten D, Marquez-Julio A, Granger P, Hayduk K, Karsunky KP, Boucher R, Genest J. Renin in dog brain. Am J Physiol 1971; 221: 1733-7.
3. 3. Ganten D, Speck G. The brain renin-angiotensin system: A model for the synthesis of peptides in the brain. Biochem Pharmacol 1978; 27: 2379-89.
4. 4. Phillips MI, Weyhenmeyer JA, Felix D, Ganten D. Evidence for an endogenous brain renin angiotensin system. Fed Proc 1979; 38: 2260-6.
5. 5. Wright JW, Roberts KA, Harding JW. Drinking to intracerebroventricularly infused angiotensin II, III and IV in the SHR. Peptides 1988; 9: 979-84.
6. 6. Wright JW, Jensen LL, Roberts KA, Sardinia MF, Harding JW. Structure-function analysis of brain angiotensin control of presser action in rats. Am J Physiol 1989; 257: R1551-7.
7. 7. Rivier C, Val W. Effect of angiotensin II on ACTH release in vivo: role of corticotrop in-releasing factor. Regul Pept 1983; 4: 253-8.
8. 8. Steele MK. Effects of angiotensins injected into various brain areas on luteinizing hormone release in the female rats. Neuroendocrinology 1987; 46: 401-5.
9. 9. Ramsay DJ, Keil LC, Sharpe MC, Shinsako J. Angiotensin II increase vasopressin, ACTH and 11-hydroxycorticosteroid secretion. Am J Physiol 1978; 234: R66-R71.
10. 10. Steele MK, Negro-Vilar A, McCann A. Effect of angiotensin on in vivo and in vitro release of anterior pituitary hormones in female rat. Endocrinology 1981; 109: 893-9.
11. 11. Baranowska D, Braszko JJ, Wiśniewski K. Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats, Psychopharmacology 1983; 81: 247-51.
12. 12. Yonkov DI, Georgiev VP, Opitz MJ. Participation of angiotensin II in learning and memory. II. Interactions of angiotensin II with dopaminergic drugs. Methods Find Exp Clin Pharmacol 1986; 8: 203-6.
13. 13. Braszko JJ, Wiśniewski K, Kupryszewski G, Witczuk B. Psychotropic effects of angiotensin II and III in rats: locomotor and exploratory vs cognitive behaviour. Behav Brain Res 1987; 25: 195-203.
14. 14. Santos RAS, Campagnole-Santos MJ. Central and peripheral actions of angiotensin-(1-7). Braz J Med Biol Res 1994; 27: 1033-47.
15. 15. Braszko JJ, Wiśniewski K, Kupryszewski G, Witczuk B. Angiotensin II(3-8) - hexapeptide affects motor activity, performance of passive avoidance and conditioned avoidance response in rats. Neuroscience 1988; 27: 777-83.
16. 16. Braszko JJ, Własienko J, Koziołkiewicz W, Janecka A, Wiśniewski K. The 3-7 fragment of angiotensin II is probably responsible for its psychoactive properties. Brain Res 1991; 542: 49-54.
17. 17. Hoły Z, Braszko J, Kupryszewski G, Witczuk B, Wiśniewski K. Angiotensin II-derived peptides devoid of phenylalanine in position 8 have full psychotropic activity of the parent hormone. J Physiol Pharmacol 1992; 43: 183-92.
18. 18. Mann JFE, Schiller PW, Schriftrin EL, Boucher R, Genest J. Brain receptor binding and central actions of angiotensin analogs in rats. Am J Physiol 1981; 241: R124-R129.
19. 19. Braszko JJ, Kulakowska A, Wiśniewski K. Angiotensin II and its 3-7 fragment improve recognition but not spatial memory in rats. Brain Res Bull 1995; 37: 627-31.
20. 20. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, Timmermans PBMWM. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989; 165: 196-203.
21. 21. Whitebread S, Mele M, Kamber B, de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989; 163: 284-91.
22. 22. Bumpus FM, Catt KJ, Chiu AT, de Gasparo M, Godfriend T, Husain A, Peach MJ, Taylor DG, Timmermans PBMWM. Nomenclature for angiotensin receptors. Hypertension 1991; 17: 720-1.
23. 23. Harding JW, Cook VI, Miller-Wing AV, Hanesworth JM, Sardinia MF, Hall KL, Stobb JW, Swanson GN, Coleman JKM, Wright JW, Harding EC. Identification of AII(S-8) [AIV] binding site in guinea pig hippocampus. Brain Res 1992; 583: 340-3.
24. 24. Miller-Wing AV, Hanesworth JM, Sardinia MF, Wright JW, Speth RC, Grove KL, Harding JW. Central angiotensin IV receptors: distribution and specificity in guinea pig brain. J Pharmacol Exp Ther 1993; 266: 1718-26.
25. 25. Wright JW, Miller-Wing AV, Shaffer MJ, Higginson C, Wright DE, Hanesworth JM, Harding JW. Angiotensin II(3-8) (ANG IV) hippocampal binding : potential role in the facilitation of memory. Brain Res Bull 1993; 32: 497-502.
26. 2) in rat brain. Am J Physiol 1991; 261: R209-16.
27. 27. Tsutsumi K, Saavedra JM. Quantitative autoradiography reveals different angiotensin II receptor subtypes in selected rat brain nuclei. J Neurochem 1991; 56: 348-51.
28. 28. Tsutsumi K, Viswanathan M, Stroemberg C, Saavedra JM. Type-1 and type-2 angiotensin II receptors in fetal rat brain. Eur J Pharmacol 1991; 198: 89-92.
29. 29. Rowe BP, Saylor DL, Speth RC. Analysis of angiotensin II receptor subtypes in individual rat brain nuclei. Neuroendocrinol 1992; 55: 563-73.
30. 30. Janiak P, Pillon A, Prost JF, Vilaine JP. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 1992; 20: 737-45.
31. 2 receptors regulate cerebral blood flow in rats. NeuroReport 1992; 3: 703-4.
32. 32. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PBMWM. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihyper tensive agent. J Pharmacol Exp Ther 1990; 252: 719-25.
33. 2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Brain Res 1992; 586: 289-94.
34. 34. Ader R, Weijnen JAWM, Moleman P. Retention of a passive avoidance responses as a function of the intensity and duration of electric shock. Psychom Sci 1972; 26: 125-9.
35. 35. Ennaceur A, Meliani K. A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs. non-spatial working memory. Behav Brain Res 1992; 51: 83-92.
36. 36. Pellow S, Chopin P, Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14: 149-67.
37. 37. Kennedy LA, Zigmond MJ. The behavioural effects of D-amphetamine are correlated with its effects on cAMP in different brain regions. Brain Res 1979; 168: 408-13.
38. 1 receptor is essential for full agonism. J Biol Chem 1995; 270: 12846-50.
39. 39. Wiśniewski K, Baranowska D, Braszko JJ. Unspecific central action of angiotensin II (ANG II). Naunyn-Schmiedeberg's Arch Pharmacol 1980; 313 (Suppl.): 227.
40. 40. Wiśniewski K, Braszko JJ. The significance of central monoamine systems in the angiotensin II (AII) improvement of learning. Clin Exp Hypertens 1984; A6: 2127-31.
41. 2 adrenergic receptor blockade influences angiotensin II facilitation of avoidance behavior and stereotypy in rats. Psychoneuroendocrinol 1990; 15: 239-52.
42. 42. Chiu AT, McCall DE, Price WA, Wong PC, Carini DJ. In vitro pharmacology of DuP 753, a nonpeptide AII receptor antagonist. Am J Hypertens 1991; 4: 282S-7S.
43. 43. Winnicka MM, Boguszewicz J, Braszko JJ. Lesions of central amygdala abolish angiotensin II improvement of recall in passive avoidance situation. Pol J Pharmacol Pharm 1988; 40: 129-34.
44. 44. Winnicka MM, Braszko JJ. 6-OHDA lesions to the central amygdala abolish angiotensins facilitation of object recognition in rats. Gen Pharmacol 1997; 29: 239-43.
45. 45. Winnicka MM, Braszko JJ, Wiśniewski K. 6-OHDA lesions to amygdala and hippocampus attenuate memory enhancing effect of the 3-7 fragment of angiotensin II. Gen Pharmacol (in press).
46. 46. Banks RJA, Dourish CT. The angiotensin receptor antagonists DuP 753 and WL 19 block apomorphine-induced stereotypy in the rat. Br J Pharmacol 1991; 104 (Oct Suppl.): 63.
47. 47. Dwoskin LP, Jewell AL, Cassis LA. Dup 753, a nonpeptide angiotensin II-1 receptor antagonist, alters dopaminergic function in rat striatum. Naunyn-Schmiedeberg's Arch Pharmacol 1992; 345: 153-9.
48. 48. Barnes JM, Barnes NM, Costall B, Kelly ME, Murphy DA, Naylor RJ. Anxiolytic-like and cognitive enhancing action of the nonpeptide angiotensin II receptor antagonist, DuP 753. In: Mac Gregor GA, Sever PS, eds. Current advances in ACE inhibition 2. London: Churchill Livingstone, 1991: 260-4.
49. 49. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979; 205: 929-32.
50. 50. Hori K, Tanaka J, Nomura M. Effects of discrimination learning on the rat amygdala dopamine release: a microdialysis study. Brain Res 1993; 621: 296-300.
51. 3 receptors of rat and guinea pig brain. Eur J Pharmacol 1994; 256: 73-8.
52. 3 receptors in the conscious rat. Br J Pharmacol 1995; 114: 1563-70.
53. 53. Laufer R, Wormser U, Friedman ZY, Gilon C, Chorev M, Selinger Z. Neurokinin B is a prefered agonist for a neuronal substance P receptor and its action is antagonised by enkephalin. Proc Natl Acad Sci USA 1985; 82: 7444.
54. 54. Whishaw IQ, O'Connor WT, Dunnet SB. Disruption of central cholinergic system in the rat by basal forebrain lesion or atropine: Effects of feeding, sensorimotor behaviour, locomotor activity and spatial navigation. Behav Brain Res 1985; 17: 103-15.
55. 55. Kesner RP, DiMattia BV. Neurobiology of an attribute model of memory. In: Morrison AR, Epstein AN, eds. Progress in psychobiology and physiological psychology. New York: Academic Press, 1987: 207-77.
56. 56. Kesner RP, Bolland BL, Dakis M. Memory for spatial locations, motor responses, and objects: Triple dissociation among the hippocampus, caudate nucleus, and extrastriate visual cortex. Exp Brain Res 1993; 93: 462-70.
57. 57. Braszko JJ, Wlasienko J, Kupryszewski G, Witczuk B, Wisniewski K. Behavioral effects of angiotensin II and angiotensin II-(4-8)-pentapeptide in rats. Physiol Behav 1988; 44: 327-32.